Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Onpattro
Onpattro
Alnylam Pharmaceuticals Is Launched and Ready for More
Motley Fool
Tue, 02/12/19 - 11:32 am
Alnylam
ATTR amyloidosis
Onpattro
Alnylam CEO talks politics, gene therapy and not becoming Pfizer
BioPharma Dive
Sun, 12/16/18 - 12:12 am
Alnylam
RNAi
Onpattro
Pharma CEOs
John Maraganore
Alnylam's Onpattro sales look 'disappointing' in early days of RNAi launch: analyst
Fierce Pharma
Mon, 11/19/18 - 11:31 am
Alnylam
RNAi
Onpattro
hATTR amyloidosis
FDA clears rare disease therapy from Akcea, Ionis
Biopharma Dive
Fri, 10/5/18 - 09:38 pm
FDA
Akcea
Ionis Pharmaceuticals
Tegsedi
Onpattro
Alnylam
hATTR amyloidosis
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Fri, 09/28/18 - 10:34 am
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
CP Wire
Fri, 09/14/18 - 09:40 am
Alnylam
Patisiran
hATTR amyloidosis
Onpattro
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
Xconomy
Thu, 08/30/18 - 10:20 am
RNAi
Alynylam
Europe
Onpattro
hATTR
Patisiran
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
Motley Fool
Tue, 08/28/18 - 10:18 am
Alnylam
Onpattro
Pfizer
ATTR amyloidosis
tafamidis
Vyndaqel
2 Blockbuster New Drug Launches Making Investors Nervous Right Now
Motley Fool
Sun, 08/26/18 - 12:01 pm
drug launches
Alnylam
GW Pharma
Onpattro
Epidiolex
3 Things Alnylam's Management Wants Investors to Know About the Launch of Onpattro
Motley Fool
Mon, 08/20/18 - 10:05 am
Alnylam
Onpattro
hATTR amyloidosis
drug pricing
labeling
2 Reasons Alnylam Stock Fell on a Landmark Drug Approval
Motley Fool
Fri, 08/17/18 - 09:25 pm
Alnylam
FDA
Onpattro
hATTR amyloidosis
3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug
Motley Fool
Wed, 08/15/18 - 10:13 pm
Alnylam
Onpattro
RNAi
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Tue, 08/14/18 - 12:06 am
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
Forbes
Sun, 08/12/18 - 01:19 pm
Alnylam
FDA
drug pricing
hATTR amyloidosis
Onpattro
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Fri, 08/10/18 - 02:25 pm
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
Alnylam Pharmaceuticals Is "Launch Ready"
Motley Fool
Mon, 08/6/18 - 11:51 pm
Alnylam
FDA
Onpattro
TTRsc02
lumasiran
Pages
« first
‹ previous
1
2